Talecris Biotherapeutics Announces Teleconference and Webcast Information for Special Meeting of Shareholders

RESEARCH TRIANGLE PARK, N.C., Feb 9, 2011 /PRNewswire/ -- Talecris Biotherapeutics Holdings Corp. (Nasdaq: TLCR) announced today the webcast and teleconference information for its special meeting of shareholders, to be held on February 14, 2011 at 3:30 p.m. Eastern Time at the Research Triangle Park Marriott, 4700 Guardian Drive, Durham, North Carolina 27703. Shareholders at the meeting will vote on the previously announced merger agreement under which Grifols (GRF.MC) will acquire TLCR.

Investors and analysts may participate in a listen-only mode by calling 1-888-713-4199 (domestic) or 1-617-213-4861 (international) and entering passcode number 93263113. To ensure timely access, please dial into the call approximately 10 minutes prior to it start time. The listen-only webcast will also be available through the Investor Relations section of http://www.talecris.com.

About Talecris Biotherapeutics: Inspiration. Dedication. Innovation.

Talecris Biotherapeutics is a global biotherapeutic and biotechnology company that discovers, develops and produces critical care treatments for people with life-threatening disorders in a variety of therapeutic areas including immunology, pulmonology, neurology and hemostasis. For more information, please visit: www.talecris.com.

SOURCE Talecris Biotherapeutics Holdings Corp.